Nifty
Sensex
:
:
11153.65
37734.08
-96.90 (-0.86%)
-300.06 (-0.79%)

Pharmaceuticals & Drugs - Domestic

Rating :
60/99

BSE: 531349 | NSE: PANACEABIO

184.60
22-Sep-2020
  • Open
  • High
  • Low
  • Previous Close
  •  186.60
  •  192.00
  •  182.25
  •  191.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  56197
  •  104.00
  •  263.35
  •  85.95

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,136.51
  • N/A
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,759.52
  • N/A
  • 7.22

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 73.59%
  • 10.71%
  • 13.31%
  • FII
  • DII
  • Others
  • 0%
  • 1.28%
  • 1.11%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -6.56
  • -7.85
  • -5.66

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -6.35
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -3.98
  • -9.58
  • -5.93

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.45
  • 12.65
  • 9.61

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
132.76
125.78
5.55%
125.36
119.60
4.82%
167.74
110.38
51.97%
125.18
120.33
4.03%
Expenses
110.22
102.40
7.64%
148.23
259.70
-42.92%
130.90
84.81
54.35%
131.18
130.22
0.74%
EBITDA
22.54
23.38
-3.59%
-22.87
-140.10
-
36.84
25.57
44.08%
-6.00
-9.89
-
EBIDTM
16.98%
18.59%
-18.24%
-117.14%
21.96%
23.17%
-4.79%
-8.22%
Other Income
1.19
5.03
-76.34%
17.98
2.24
702.68%
3.23
3.29
-1.82%
3.45
1.71
101.75%
Interest
45.23
40.80
10.86%
44.46
23.99
85.33%
47.24
-14.14
-
41.48
29.36
41.28%
Depreciation
11.33
11.36
-0.26%
10.05
12.86
-21.85%
10.73
51.96
-79.35%
11.08
13.51
-17.99%
PBT
-32.83
-23.75
-
-59.40
186.14
-
-17.90
-8.96
-
-70.50
-98.55
-
Tax
0.34
2.83
-87.99%
9.15
2.63
247.91%
2.31
4.90
-52.86%
2.35
-2.45
-
PAT
-33.17
-26.58
-
-68.55
183.51
-
-20.21
-13.86
-
-72.85
-96.10
-
PATM
-24.98%
-21.13%
-54.68%
153.44%
-12.05%
-12.56%
-58.20%
-79.86%
EPS
-5.41
-4.34
-
-11.18
29.94
-
-3.30
-2.26
-
-11.88
-15.68
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
551.04
456.70
592.79
544.01
653.08
687.19
509.99
608.49
710.09
1,167.88
900.15
Net Sales Growth
15.74%
-22.96%
8.97%
-16.70%
-4.96%
34.75%
-16.19%
-14.31%
-39.20%
29.74%
 
Cost Of Goods Sold
168.16
172.24
187.25
149.52
215.81
280.21
214.00
263.41
347.57
533.58
471.99
Gross Profit
382.88
284.45
405.55
394.50
437.27
406.98
295.99
345.08
362.52
634.30
428.16
GP Margin
69.48%
62.28%
68.41%
72.52%
66.96%
59.22%
58.04%
56.71%
51.05%
54.31%
47.57%
Total Expenditure
520.53
589.83
508.26
496.89
541.37
643.31
592.00
694.55
796.40
899.47
788.42
Power & Fuel Cost
-
34.55
33.52
30.55
25.15
30.73
31.74
37.76
29.26
22.53
13.09
% Of Sales
-
7.57%
5.65%
5.62%
3.85%
4.47%
6.22%
6.21%
4.12%
1.93%
1.45%
Employee Cost
-
147.08
151.59
148.12
142.02
135.98
144.92
146.94
160.72
143.35
97.05
% Of Sales
-
32.20%
25.57%
27.23%
21.75%
19.79%
28.42%
24.15%
22.63%
12.27%
10.78%
Manufacturing Exp.
-
44.31
40.05
41.88
39.47
43.97
52.69
67.15
50.82
45.45
95.82
% Of Sales
-
9.70%
6.76%
7.70%
6.04%
6.40%
10.33%
11.04%
7.16%
3.89%
10.64%
General & Admin Exp.
-
43.17
40.39
52.98
39.41
56.82
60.39
73.47
75.49
94.21
61.13
% Of Sales
-
9.45%
6.81%
9.74%
6.03%
8.27%
11.84%
12.07%
10.63%
8.07%
6.79%
Selling & Distn. Exp.
-
31.27
36.98
37.70
44.20
44.20
46.09
48.87
57.65
48.15
42.15
% Of Sales
-
6.85%
6.24%
6.93%
6.77%
6.43%
9.04%
8.03%
8.12%
4.12%
4.68%
Miscellaneous Exp.
-
117.21
18.48
36.14
35.31
51.40
42.17
56.95
74.89
12.20
42.15
% Of Sales
-
25.66%
3.12%
6.64%
5.41%
7.48%
8.27%
9.36%
10.55%
1.04%
0.80%
EBITDA
30.51
-133.13
84.53
47.12
111.71
43.88
-82.01
-86.06
-86.31
268.41
111.73
EBITDA Margin
5.54%
-29.15%
14.26%
8.66%
17.11%
6.39%
-16.08%
-14.14%
-12.15%
22.98%
12.41%
Other Income
25.85
5.06
8.23
46.59
20.35
28.48
15.36
5.44
8.83
16.11
93.63
Interest
178.41
104.83
100.58
100.93
127.33
104.53
150.30
103.76
100.71
55.62
42.62
Depreciation
43.19
55.03
58.53
67.95
73.32
67.24
71.10
85.99
77.13
74.53
49.96
PBT
-180.63
-287.93
-66.35
-75.17
-68.59
-99.41
-288.05
-270.37
-255.32
154.37
112.78
Tax
14.15
8.56
9.86
-10.98
1.92
3.08
1.68
-18.76
-54.19
21.89
40.36
Tax Rate
-7.83%
18.58%
-14.86%
16.28%
-10.14%
-3.10%
-1.51%
7.41%
21.22%
14.18%
35.79%
PAT
-194.78
37.58
-74.18
-54.75
-18.51
-100.70
-111.56
-234.30
-201.13
132.49
72.42
PAT before Minority Interest
-194.80
37.52
-76.20
-56.47
-20.85
-102.49
-112.64
-234.30
-201.13
132.48
72.42
Minority Interest
-0.02
0.06
2.02
1.72
2.34
1.79
1.08
0.00
0.00
0.01
0.00
PAT Margin
-35.35%
8.23%
-12.51%
-10.06%
-2.83%
-14.65%
-21.87%
-38.51%
-28.32%
11.34%
8.05%
PAT Growth
-514.69%
-
-
-
-
-
-
-
-
82.95%
 
EPS
-31.77
6.13
-12.10
-8.93
-3.02
-16.43
-18.20
-38.22
-32.81
21.61
11.81

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
350.40
308.68
355.68
448.61
471.29
512.72
625.69
875.12
654.03
700.73
Share Capital
6.13
6.13
6.13
22.43
22.43
6.13
6.13
6.13
6.13
6.68
Total Reserves
344.27
302.55
349.55
426.18
448.76
506.59
619.56
868.99
647.90
694.05
Non-Current Liabilities
70.08
591.13
718.78
1,100.11
918.47
767.07
865.20
720.28
502.53
778.13
Secured Loans
8.10
560.45
704.57
866.08
721.77
581.77
688.31
509.82
421.82
508.14
Unsecured Loans
38.02
10.26
9.49
1.00
1.20
1.40
1.60
2.70
1.90
198.98
Long Term Provisions
39.78
26.54
18.36
184.42
180.43
180.47
171.27
170.81
2.99
0.00
Current Liabilities
938.26
695.52
689.13
474.80
706.03
826.82
509.96
516.52
576.06
331.50
Trade Payables
269.71
277.19
248.60
187.87
209.13
252.11
175.69
122.21
97.38
147.49
Other Current Liabilities
585.25
242.00
237.52
93.60
194.85
251.91
49.82
134.72
101.62
5.74
Short Term Borrowings
69.39
164.88
190.71
191.82
295.84
320.67
274.00
249.54
363.94
0.00
Short Term Provisions
13.92
11.44
12.30
1.51
6.21
2.13
10.45
10.05
13.12
178.27
Total Liabilities
1,355.73
1,592.38
1,774.13
2,024.60
2,099.21
2,112.09
2,008.20
2,118.52
1,733.86
1,815.20
Net Block
805.56
948.97
1,001.37
1,071.11
1,144.30
1,275.54
1,154.49
1,195.10
684.74
691.42
Gross Block
1,392.90
1,605.84
1,600.07
1,620.29
1,633.48
1,697.63
1,694.13
1,638.61
1,039.99
973.71
Accumulated Depreciation
587.34
656.87
598.70
549.18
489.18
422.09
539.64
443.51
355.25
282.29
Non Current Assets
847.84
1,027.55
1,070.91
1,475.22
1,573.49
1,739.28
1,574.45
1,617.03
920.19
936.05
Capital Work in Progress
22.51
39.92
30.41
115.78
110.31
116.55
135.26
90.83
118.90
162.16
Non Current Investment
5.33
5.25
7.01
5.19
10.20
15.97
16.51
30.91
56.58
72.67
Long Term Loans & Adv.
13.33
28.01
22.03
236.71
262.44
274.94
266.34
293.65
56.67
0.00
Other Non Current Assets
1.12
5.39
10.09
1.26
1.07
0.35
1.85
6.54
3.30
0.00
Current Assets
507.89
564.83
703.22
549.38
525.72
372.81
433.75
501.49
813.67
878.95
Current Investments
0.00
2.03
0.27
3.52
4.98
0.00
5.99
1.60
0.09
0.02
Inventories
81.43
334.21
315.55
305.24
310.22
219.81
267.94
385.26
410.63
457.68
Sundry Debtors
88.73
136.01
142.17
141.67
98.57
94.93
69.86
68.38
275.57
107.59
Cash & Bank
23.48
23.24
14.13
22.93
52.40
24.78
39.23
15.51
48.94
47.04
Other Current Assets
314.25
10.06
174.88
9.26
59.55
33.29
50.73
30.74
78.44
266.62
Short Term Loans & Adv.
41.02
59.30
56.21
66.76
50.15
24.72
44.44
19.33
70.61
262.77
Net Current Assets
-430.38
-130.69
14.08
74.58
-180.31
-454.01
-76.21
-15.03
237.61
547.45
Total Assets
1,355.73
1,592.38
1,774.13
2,024.60
2,099.21
2,112.09
2,008.20
2,118.52
1,733.86
1,815.20

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
104.88
118.02
130.67
90.69
37.23
53.73
-24.02
228.09
78.03
62.17
PBT
46.23
-66.14
-67.18
-18.93
-99.41
-110.96
-253.06
-255.32
154.37
112.77
Adjustment
-70.50
166.62
149.57
148.75
167.45
59.92
161.18
200.35
71.70
-42.14
Changes in Working Capital
127.32
21.45
43.32
-58.26
-25.16
107.22
68.23
287.84
-127.30
4.23
Cash after chg. in Working capital
103.05
121.93
125.71
71.56
42.88
56.18
-23.65
232.87
98.77
74.86
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
1.83
-3.91
4.96
19.13
-5.65
-2.45
-0.37
-4.78
-20.74
-12.69
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-5.35
55.29
-25.83
16.44
-37.38
-37.60
-61.19
-123.91
12.03
-117.18
Net Fixed Assets
762.66
-15.06
-27.48
11.93
-29.48
-5.26
-31.39
-481.95
-30.24
-59.90
Net Investments
342.34
0.00
49.78
0.00
-0.46
-122.35
-13.38
-25.53
-7.09
-9.28
Others
-1,110.35
70.35
-48.13
4.51
-7.44
90.01
-16.42
383.57
49.36
-48.00
Cash from Financing Activity
-101.14
-164.35
-106.96
-117.38
-0.70
-30.26
104.89
-133.63
-85.21
27.56
Net Cash Inflow / Outflow
-1.61
8.97
-2.13
-10.25
-0.85
-14.13
19.68
-29.45
4.85
-27.45
Opening Cash & Equivalents
16.44
7.47
9.59
19.97
20.84
34.95
15.16
44.26
39.58
67.80
Closing Cash & Equivalent
14.47
16.44
7.47
9.73
19.99
20.84
34.95
15.16
44.26
39.58

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
57.21
50.40
58.07
-4.43
-0.75
13.96
34.08
72.93
106.69
104.87
ROA
2.55%
-4.53%
-2.97%
-1.01%
-4.87%
-5.47%
-11.36%
-10.44%
7.47%
3.97%
ROE
11.39%
-22.94%
-34.38%
0.00%
-253.03%
-76.49%
-71.43%
-36.53%
19.56%
11.08%
ROCE
13.44%
2.63%
2.76%
9.93%
0.45%
3.37%
-11.89%
-10.89%
14.36%
11.44%
Fixed Asset Turnover
0.30
0.37
0.35
0.40
0.41
0.30
0.37
0.53
1.16
0.96
Receivable days
89.81
85.16
92.84
67.10
51.36
58.89
41.39
88.28
59.86
46.14
Inventory Days
166.09
198.91
203.06
171.89
140.68
174.32
195.55
204.27
135.65
184.13
Payable days
213.56
186.55
163.89
130.73
137.37
148.94
82.64
57.15
38.43
27.63
Cash Conversion Cycle
42.34
97.52
132.00
108.26
54.67
84.27
154.30
235.40
157.07
202.63
Total Debt/Equity
1.85
3.05
2.79
-100.22
93.42
12.38
4.69
1.96
1.32
1.01
Interest Cover
1.44
0.34
0.33
0.85
0.05
0.26
-1.44
-1.54
3.78
3.65

News Update:


  • Panacea Biotec terminates MoU with Refana for COVID-19 vaccine
    24th Aug 2020, 15:30 PM

    Termination is due to delays in project timelines and difficulty in moving ahead with the joint venture

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.